PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q1 2023. The put-call ratio across all filers is 8.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,930 | -27.2% | 23,300 | -0.9% | 0.00% | -100.0% |
| Q2 2023 | $67,210 | -3.8% | 23,500 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $69,840 | -5.4% | 24,000 | -4.8% | 0.00% | 0.0% |
| Q4 2022 | $73,836 | +23.1% | 25,200 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $60,000 | +1.7% | 24,800 | -5.3% | 0.00% | 0.0% |
| Q2 2022 | $59,000 | -1.7% | 26,200 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $60,000 | -21.1% | 26,300 | -13.5% | 0.00% | 0.0% |
| Q4 2021 | $76,000 | -72.9% | 30,400 | -65.5% | 0.00% | -66.7% |
| Q3 2021 | $280,000 | – | 88,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
| SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
| K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
| EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
| CSS LLC/IL | 13,186 | $27,691 | 0.00% |
| Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
| Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |